Product Dossier
ADRIAMYCIN
Product Dossier for ADRIAMYCIN (doxorubicin hydrochloride, Pfizer). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pfizer
- Active ingredient: doxorubicin hydrochloride
- Therapeutic area: Oncology
- Related brand: CAELYX
- Same area: TALZENNA
- Same area: ZARZIO
What it is
ADRIAMYCIN is doxorubicin hydrochloride supplied as an injection for intravenous or intravesical administration.
PBS listing
ADRIAMYCIN doxorubicin hydrochloride 50 mg in 25 mL single dose vial is listed on the PBS as an unrestricted item with two PBS items, with an ex-manufacturer price of A$19.49.
Regulatory history
ADRIAMYCIN was first registered on the ARTG on 23 September 1991 as a 10 mg/5 mL injection vial. The 20 mg/10 mL and 50 mg/25 mL injection vials were listed on 6 December 1993.